ongo
histor
outbreak
constitut
global
public
health
crisi
also
carri
devast
social
econom
impact
diseas
caus
newli
identifi
coronaviru
sever
acut
respiratori
syndrom
coronaviru
urgent
need
identifi
antivir
curtail
pandem
herein
report
remark
sensit
recombin
human
interferon
treatment
concentr
intern
unit
iu
per
millilit
drastic
reduc
viral
titer
log
log
respect
vero
cell
treatment
iuml
iuml
respect
vero
cell
result
suggest
sensit
mani
human
pathogen
virus
includ
sarscov
overal
result
demonstr
potent
efficaci
human
type
ifn
suppress
infect
find
could
inform
futur
treatment
option
therefor
urgent
need
find
treatment
drug
alreadi
approv
treatment
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
diseas
may
offer
expedi
option
treat
sever
drug
alreadi
test
clinic
trial
type
interferon
broad
spectrum
antivir
activ
rna
virus
act
induc
antivir
respons
across
wide
rang
cell
type
mediat
adapt
immun
respons
human
produc
type
singular
type
ifn
ultim
induc
number
stimul
gene
isg
encod
varieti
antivir
effector
notabl
product
lead
posit
feedback
loop
stimul
express
mani
gene
clinic
type
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
vero
cell
well
seed
plate
h
treat
human
mammalian
monolay
wash
pb
three
time
remov
dead
cell
fix
formaldehyd
fig
peak
viru
titer
moi
moi
indic
viral
replic
effici
low
moi
high
moi
addit
viru
infect
caus
strong
cytopath
effect
cpe
evid
hpi
much
later
peak
viru
product
hpi
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
return
cell
incub
hour
supernat
collect
viral
titer
determin
via
assay
result
indic
treatment
potent
inhibit
infect
viru
titer
detect
except
lowest
concentr
test
iuml
viral
titer
drastic
reduc
log
magnitud
fig
viru
titer
detect
limit
concentr
test
indic
potent
activ
consist
cpe
observ
microscop
examin
ifntreat
sampl
next
test
antivir
efficaci
lower
concentr
iuml
dosedepend
inhibit
viru
infect
lower
concentr
fig
exhibit
anti
activ
concentr
low
iuml
result
signific
reduct
viral
titer
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
data
clearli
demonstr
highli
sensit
treatment
cultur
cell
compar
ifnsensit
vsv
discoveri
reveal
weak
new
compar
seem
sarscov
rel
less
sensit
ifn
treatment
vitro
one
studi
report
sarscov
iuml
depend
viru
strain
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
therefor
drug
may
potenti
repurpos
treatment
either
alon
combin
antivir
therapi
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
